BRIEF-US Patent and Trademark Office issues immunotehrapy patent to Adma Biologics – Reuters

BRIEF-US Patent and Trademark Office issues immunotehrapy patent to Adma Biologics – Reuters
BRIEF-US Patent and Trademark Office issues immunotehrapy patent to Adma BiologicsReuters… * Adma Biologics – U.S. Patent and trademark office has issued to co U.S. Patent no. 9,714,283 which encompasses methods of providing immunotherapy to patients. * Adma Biologics Inc – the term of this newly issued patent extends to January 2035 …
BRIEF-US Patent and Trademark Office issues immunotehrapy patent to Adma Biologics – Reuters